A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumoursSarah P. Blagden, Mark R. Middleton, A Seebaran et al.|British Journal of Cancer|2008Cited by 82
Phase I study of ispinesib (SB-715992) in combination with docetaxel in patients with advanced solid tumors.Sarah P. Blagden, Mark R. Middleton, Alison Reid et al.|Clinical Cancer Research|2005Cited by 1